Martin Dreyling Selected Research

Martin Dreyling Research Topics

Disease

96	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 05/2024 - 01/2003
63	Lymphoma (Lymphomas) 03/2024 - 01/2003
45	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 01/2024 - 01/2003
30	Non-Hodgkin Lymphoma (Lymphosarcoma) 03/2024 - 01/2003
26	Neoplasms (Cancer) 11/2022 - 01/2005
22	B-Cell Lymphoma (Lymphoma, B Cell) 10/2023 - 04/2006
19	Disease Progression 01/2023 - 06/2003
13	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 07/2022 - 04/2006
13	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2020 - 09/2004
11	Genetic Translocation (Chromosomal Translocation) 01/2017 - 01/2009
8	Infections 05/2024 - 02/2009
5	Residual Neoplasm 11/2023 - 03/2006
4	Neutropenia 12/2021 - 03/2014
4	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2021 - 07/2003
3	Cytokine Release Syndrome 04/2023 - 06/2015
3	Hyperglycemia 11/2021 - 01/2019
3	Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma) 01/2021 - 09/2010
3	Diarrhea 01/2019 - 03/2014
3	Hodgkin Disease (Hodgkin's Disease) 01/2016 - 04/2006
2	COVID-19 02/2023 - 07/2021
2	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 02/2023 - 10/2008
2	Thrombocytopenia (Thrombopenia) 02/2023 - 04/2010
2	Hematologic Neoplasms (Hematological Malignancy) 01/2023 - 12/2004
2	T-Cell Lymphoma (Lymphoma, T Cell) 01/2022 - 09/2010
2	Inflammation (Inflammations) 12/2021 - 10/2018
2	Hypertension (High Blood Pressure) 11/2021 - 01/2019
2	Hemorrhage 01/2019 - 08/2015
2	Pneumonia (Pneumonitis) 01/2019 - 03/2014
2	Multiple Myeloma 01/2016 - 02/2010
2	Chromosome Aberrations (Chromosome Abnormalities) 03/2012 - 02/2009
2	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 07/2011 - 12/2007
2	Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral) 09/2010 - 03/2010

Drug/Important Bio-Agent (IBA)

54	Rituximab (Mabthera)FDA Link 04/2024 - 01/2003
21	Cyclophosphamide (Cytoxan)FDA LinkGeneric 10/2023 - 01/2003
19	Bendamustine Hydrochloride FDA Link 12/2022 - 07/2007
17	ibrutinibIBA 05/2024 - 08/2013
16	Vincristine (Oncovin)FDA LinkGeneric 01/2023 - 12/2004
16	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2023 - 12/2004
14	Cyclin D1IBA 01/2017 - 10/2008
12	Cytarabine (Cytosar-U)FDA LinkGeneric 04/2024 - 05/2009
12	Agammaglobulinaemia Tyrosine KinaseIBA 10/2023 - 08/2013
12	Prednisone (Sone)FDA LinkGeneric 01/2023 - 12/2004
12	Monoclonal AntibodiesIBA 01/2021 - 11/2004
10	Bortezomib (Velcade)FDA Link 04/2024 - 06/2003
9	Proteins (Proteins, Gene)FDA Link 10/2021 - 11/2006
8	tisagenlecleucelIBA 01/2024 - 12/2021
8	temsirolimus FDA Link 12/2023 - 06/2013
8	Biomarkers (Surrogate Marker)IBA 12/2021 - 08/2007
8	fludarabineIBA 01/2021 - 01/2003
7	Chimeric Antigen ReceptorsIBA 04/2023 - 11/2019
7	Lenalidomide (CC 5013)FDA Link 01/2021 - 09/2008
6	AntibodiesIBA 07/2021 - 06/2003
5	Dexamethasone (Maxidex)FDA LinkGeneric 04/2024 - 08/2016
5	Proteasome InhibitorsIBA 10/2023 - 09/2008
5	copanlisibIBA 11/2021 - 12/2017
5	AntigensIBA 05/2021 - 01/2007
5	Mitoxantrone (Novantrone)FDA LinkGeneric 07/2007 - 01/2003
4	obinutuzumabIBA 07/2023 - 02/2015
4	DNA (Deoxyribonucleic Acid)IBA 09/2015 - 09/2009
3	Cisplatin (Platino)FDA LinkGeneric 01/2023 - 08/2016
3	Prednisolone (Predate)FDA LinkGeneric 12/2022 - 06/2014
3	Complement System Proteins (Complement)IBA 11/2022 - 01/2005
3	axicabtagene ciloleucelIBA 07/2022 - 01/2021
3	CytokinesIBA 12/2021 - 10/2018
3	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 11/2021 - 12/2017
3	Interferon-alpha (Interferon Alfa)IBA 09/2021 - 11/2004
3	purineIBA 01/2021 - 09/2004
3	tafasitamabIBA 01/2021 - 01/2020
3	idelalisibIBA 04/2016 - 03/2014
3	Alkylating AgentsIBA 01/2015 - 02/2010
2	venetoclaxIBA 04/2024 - 01/2018
2	Gemcitabine FDA Link 03/2024 - 01/2022
2	Oxaliplatin (Eloxatin)FDA LinkGeneric 03/2024 - 01/2022
2	brexucabtagene autoleucelIBA 11/2023 - 10/2023
2	VaccinesIBA 02/2023 - 10/2008
2	TOR Serine-Threonine KinasesIBA 11/2021 - 09/2008
2	AutoantigensIBA 10/2021 - 10/2008
2	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 07/2021 - 01/2021
2	Etoposide (VP 16)FDA LinkGeneric 04/2021 - 01/2021
2	LigandsIBA 10/2019 - 01/2015
2	Protein Isoforms (Isoforms)IBA 01/2019 - 12/2017
2	B-Cell Antigen Receptors (B Cell Antigen Receptors)IBA 10/2017 - 01/2016
2	Proteasome Endopeptidase Complex (Proteasome)IBA 12/2014 - 03/2009
2	enzastaurinIBA 07/2014 - 02/2010
2	Immunoglobulin Heavy Chains (Immunoglobulin Heavy Chain)IBA 05/2014 - 11/2009
2	Chlorambucil (Leukeran)FDA Link 03/2011 - 09/2006

Therapy/Procedure

78	Therapeutics 04/2024 - 06/2003
38	Drug Therapy (Chemotherapy) 03/2024 - 01/2003
23	Stem Cell Transplantation 05/2024 - 11/2004
8	Salvage Therapy 01/2020 - 04/2006
6	Transplantation 10/2023 - 07/2005
6	Chemoradiotherapy 01/2023 - 11/2004
6	Radiotherapy 07/2022 - 05/2013
4	Precision Medicine 11/2022 - 06/2015
4	Radioimmunotherapy 12/2011 - 07/2005
3	Cell Transplantation 12/2021 - 05/2019
2	Hematopoietic Stem Cell Transplantation 10/2023 - 07/2013
2	Induction Chemotherapy 01/2022 - 01/2019
2	Time-to-Treatment 01/2018 - 03/2005
2	Homologous Transplantation 03/2015 - 07/2005